Custom Index Systems’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,506
Closed -$280K 287
2025
Q4
$280K Sell
5,506
-443
-7% -$22.7K 0.12% 204
2025
Q3
$330K Sell
5,949
-332
-5% -$19.4K 0.1% 207
2025
Q2
$434K Sell
6,281
-2,030
-24% -$138K 0.21% 156
2025
Q1
$577K Buy
8,311
+5,776
+228% +$477K 0.29% 95
2024
Q4
$218K Sell
2,535
-52
-2% -$5.62K 0.12% 225
2024
Q3
$308K Buy
2,587
+68
+3% +$9.07K 0.17% 188
2024
Q2
$360K Sell
2,519
-1,231
-33% -$163K 0.21% 147
2024
Q1
$482K Sell
3,750
-763
-17% -$90.8K 0.27% 98
2023
Q4
$467K Buy
+4,513
New +$446K 0.29% 86

Other funds holding NVO

Custom Index Systems's NVO Position: Q1 2026 in Review

Custom Index Systems sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,506 shares — an estimated $280K sold.

Custom Index Systems first reported a position in NVO in Q4 2023 and held it in 9 quarters. The position peaked at $577K in Q1 2025. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Custom Index Systems reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Custom Index Systems sold 5,506 Novo Nordisk shares in Q1 2026, an estimated $280K.
  • Custom Index Systems first reported a position in Novo Nordisk in Q4 2023 and held it in 9 quarters.
  • Custom Index Systems's Novo Nordisk position peaked at $577K in Q1 2025.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Custom Index Systems's 13F filing for Q1 2026, filed 29 Apr 2026.